Search research articles
Contact Us
Filters
Showing results (831-840 of 860) with videos related to
Page
of 86
Sort By:
American Heart Journal
|
May 22, 2022
The trial to assess chelation therapy 2 (TACT2): Rationale and design
Gervasio A Lamas, Kevin J Anstrom, Ana Navas-Acien, et al.
The New England Journal of Medicine
|
April 1, 2020
Health-Status Outcomes with Invasive or Conservative Care in Coronary Disease
John A Spertus, Philip G Jones, David J Maron, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 16, 2010
Inhalation by design: dual pharmacology β-2 agonists/M3 antagonists for the treatment of COPD
Lyn H Jones, Helen Baldock, Mark E Bunnage, et al.
The New Phytologist
|
May 16, 2021
Hydraulically-vulnerable trees survive on deep-water access during droughts in a tropical forest
Rutuja Chitra-Tarak, Chonggang Xu, Salomón Aguilar, et al.
Journal of the American College of Cardiology
|
March 26, 2025
Guideline-Directed Medical Therapy and Outcomes in the ISCHEMIA Trial
David J Maron, Jonathan D Newman, Rebecca Anthopolos, et al.
Nature Medicine
|
July 15, 2020
Myocardial infarction accelerates breast cancer via innate immune reprogramming
Graeme J Koelwyn, Alexandra A C Newman, Milessa S Afonso, et al.
Circulation
|
September 9, 2021
Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity
Harmony R Reynolds, Leslee J Shaw, James K Min, et al.
JAMA Internal Medicine
|
March 9, 2013
Centralized, stepped, patient preference-based treatment for patients with post-acute coronary syndrome depression: CODIACS vanguard randomized controlled trial
Karina W Davidson, J Thomas Bigger, Matthew M Burg, et al.
JACC. Cardiovascular Interventions
|
January 25, 2023
Cause-Specific Mortality in Patients With Advanced Chronic Kidney Disease in the ISCHEMIA-CKD Trial
Mandeep S Sidhu, Karen P Alexander, Zhen Huang, et al.
Lancet (London, England)
|
September 22, 2009
Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials
John J Aponte, David Schellenberg, Andrea Egan, et al.
Page
of 86
Search research articles
Search
Showing results (831-840 of 860) with videos related to
Sort By:
Page
of 86
American Heart Journal
|
May 22, 2022
The trial to assess chelation therapy 2 (TACT2): Rationale and design
Gervasio A Lamas, Kevin J Anstrom, Ana Navas-Acien, et al.
The New England Journal of Medicine
|
April 1, 2020
Health-Status Outcomes with Invasive or Conservative Care in Coronary Disease
John A Spertus, Philip G Jones, David J Maron, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 16, 2010
Inhalation by design: dual pharmacology β-2 agonists/M3 antagonists for the treatment of COPD
Lyn H Jones, Helen Baldock, Mark E Bunnage, et al.
The New Phytologist
|
May 16, 2021
Hydraulically-vulnerable trees survive on deep-water access during droughts in a tropical forest
Rutuja Chitra-Tarak, Chonggang Xu, Salomón Aguilar, et al.
Journal of the American College of Cardiology
|
March 26, 2025
Guideline-Directed Medical Therapy and Outcomes in the ISCHEMIA Trial
David J Maron, Jonathan D Newman, Rebecca Anthopolos, et al.
Nature Medicine
|
July 15, 2020
Myocardial infarction accelerates breast cancer via innate immune reprogramming
Graeme J Koelwyn, Alexandra A C Newman, Milessa S Afonso, et al.
Circulation
|
September 9, 2021
Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity
Harmony R Reynolds, Leslee J Shaw, James K Min, et al.
JAMA Internal Medicine
|
March 9, 2013
Centralized, stepped, patient preference-based treatment for patients with post-acute coronary syndrome depression: CODIACS vanguard randomized controlled trial
Karina W Davidson, J Thomas Bigger, Matthew M Burg, et al.
JACC. Cardiovascular Interventions
|
January 25, 2023
Cause-Specific Mortality in Patients With Advanced Chronic Kidney Disease in the ISCHEMIA-CKD Trial
Mandeep S Sidhu, Karen P Alexander, Zhen Huang, et al.
Lancet (London, England)
|
September 22, 2009
Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials
John J Aponte, David Schellenberg, Andrea Egan, et al.
Page
of 86